Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification-Reference-Cited by-同舟云学术

Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification

Published:2014-06-04 Issue:5 Volume:166 Page:758-766
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hasegawa Daisuke¹,Chen Xiaojuan¹²,Hirabayashi Shinsuke¹³,Ishida Yasushi¹,Watanabe Shizuka¹,Zaike Yuji⁴,Tsuchida Masahiro⁵,Masunaga Atsuko⁶,Yoshimi Ayami³,Hama Asahito⁷,Kojima Seiji⁷,Ito Masafumi⁸,Nakahata Tatsutoshi⁹,Manabe Atsushi¹

Affiliation:

1. Department of Paediatrics; St. Luke's International Hospital; Tokyo Japan

2. Department of Paediatrics; Institute of Haematology and Blood Disease Hospital; Chinese Academy of Medical Sciences; Tianjin China

3. Division of Paediatric Haematology and Oncology; Department of Paediatrics and Adolescent Medicine; University of Freiburg; Freiburg Germany

4. Clinical Laboratory; Research Hospital; The Institution of Medical Science; The University of Tokyo; Tokyo Japan

5. Paediatric Haematology/Oncology; Ibaraki Children's Hospital; Mito Japan

6. Department of Surgical Pathology; Showa University Fujigaoka Hospital; Yokohama Japan

7. Department of Paediatrics; Nagoya University Graduate School of Medicine; Nagoya Japan

8. Department of Pathology; Japanese Red Cross Nagoya First Hospital; Nagoya Japan

9. Centre for iPS Cell Research and Application; Kyoto University; Kyoto Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12955/fullpdf

Reference35 articles.

1. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria;Baumann;Histopathology,2012

2. Immunologic aspects of hypoplastic myelodysplastic syndrome;Calado;Seminars in Oncology,2011

3. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS);Cantù Rajnoldi;Annals of Hematology,2005

4. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome;Cutler;Blood,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/Neoplasms;2024-01-03

2. Childhood Myelodysplastic Syndrome;Clinics in Laboratory Medicine;2023-12

3. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia;American Journal of Hematology;2023-01-05

4. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia;Virchows Archiv;2022-11-29

5. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data;Blood;2022-09-15